HOME ·

Jiangxi Biology

JIANGXI BIOLOGY(06915.HK): Veterinary Tetanus Antitoxin Production Line Officially Put into Operation
Tags：
Jiangxi Biology06915.HK
2026-07-27
JIANGXI BIOLOGY(06915.HK): Stabilisation Period Concludes, Over-Allotment Option Lapses
Tags：
Jiangxi Biology06915.HK
2026-07-27
Jiangxi Biotech (06915.HK)Slumps 14.29% on Listing Day, Quoted at HK$9.60
Tags：
Jiangxi Biology06915.HKListingDebutIPO
2026-06-30
JIANGXI BIOLOGY(06915.HK) Launches Public Offering Today, Entry Fee Approximately HK$6,595.86
Tags：
Jiangxi Biology06915.HKIPOpublic offering
2026-06-22
Jiangxi Biology Passes HKEX Hearing, World’s Largest Provider of Human Tetanus Antitoxin
Tags：
Jiangxi BiologyIPOpass the listing hearing
2026-06-08